Finzati - Logo
SOLV logo

Solventum Corporation

SOLV • Medical - Instruments & Supplies
$86.00
▼ -0.39 (-0.45%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$15.00B
Growth
2.5%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Stable or improving margins · 18.7%Consistent free cash flow · 4/5Reasonable earnings multiple · 8.87Negative growth trend
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:26 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$86.00
Change-0.45%
Shares Out174.40M
Market Cap$15.00B
Enterprise Value$19.67B
52W Range62.38 - 90.00
Beta0.72
P/E10.46
P/S1.80
P/B3.12
P/FCF-38.36
EV/Sales2.37

Investment DNA

How strong this company looks for long-term investors

68
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
64/100
Growth Potential
Revenue and expansion
21/100
Price Attractiveness
Cheap or expensive today
89/100
Why this score▼
Stable or improving margins · 18.7%Consistent free cash flow · 4/5Reasonable earnings multiple · 8.87Negative growth trend

Analyst view

Analyst sentiment and price target

SOLV
Analyst sentiment
Based on 12 analyst votes · 2026-10-20
83/100
Bullish
Bullish
9
Hold
2
Bearish
1
Price Target
2026-08-07
Low
$43.00
Mean
$91.22
Median
$95.00
High
$113.00

Company Overview

IPO: 4/1/2024
Industry: Medical - Instruments & Supplies
P/B i: 3.12
Debt / Equity i: 1.00
Operating Margin: 26.20%
Net Margin: 18.69%
ROE i: -
ROIC: -

Financial Health

Score13 / 20
Debt / Equity: 1.00
Current Ratio: 1.23
Quick Ratio: 0.89
Status: Good

Insider Transactions

Recent executive and insider activity

Wilson Darryl L.
Transaction: 05/15/2026
BUY
Change
+3,300
Price
Not reported
Filing
05/18/2026
Type
BUY
Wendell Amy McBride
Transaction: 05/15/2026
BUY
Change
+3,300
Price
Not reported
Filing
05/18/2026
Type
BUY
WEILAND JOHN H
Transaction: 05/15/2026
BUY
Change
+3,300
Price
Not reported
Filing
05/18/2026
Type
BUY